Doug Stanton

Papers

1

Total Citations

68

H-Index

1

About

Doug Stanton is a leading figure in medical physics and interventional oncology, whose work centers on advancing image-guided brachytherapy for prostate cancer. His major contribution lies in pioneering electromagnetic (EM) tracking technology to enhance the precision of catheter reconstruction during ultrasound-guided high-dose-rate (HDR) brachytherapy. In his seminal 2014 paper, which has garnered 68 citations, Stanton demonstrated how EM sensors can replace traditional fluoroscopic methods, reducing radiation exposure and improving real-time accuracy in needle placement. This innovation directly addresses a critical bottleneck in prostate brachytherapy—the need for reliable, non-ionizing guidance—and has influenced subsequent developments in fusion imaging and robotic-assisted interventions. Beyond this flagship work, Stanton’s research portfolio spans dosimetry optimization, treatment planning algorithms, and clinical validation studies, collectively shaping modern standards for HDR brachytherapy. His contributions have been recognized through invited talks at international symposia and collaborations with leading cancer centers. For students and researchers, Stanton’s career exemplifies how engineering-driven solutions can solve real-world clinical challenges, making cancer treatment safer and more effective.

Research Focus

Key Achievements

1
H-Index
1
Papers
68
Total Citations
68
Avg Citations/Paper
🏆 Most Cited Paper
Electromagnetic tracking for catheter reconstruction in ultrasound-guided high-dose-rate brachytherapy of the prostate
68 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 7

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago